; and (2) includes the following: (A) Chagas disease. (B) Cysticercosis. (C) Toxocariasis. (D) Toxoplasmosis. (E) Trichomoniasis. (F) Hookworm infection. (G) Dengue Fever and related arbovirus infections. (H) Other neglected tropical diseases, including those defined by the World Health Organization, such as the following: (i) Buruli ulcer. (ii) Chikungunya. (iii) Dracunculiasis. (iv) Echinococcosis. (v) Foodborne trematodiases. (vi) Human African trypanosomiasis. (vii) Leishmaniases. (viii) Leprosy. (ix) Lymphatic filariasis. (x) Mycetoma. (xi) Onchocerciasis. (xii) Rabies. (xiii) Schistosomiasis. (xiv) Soil-transmitted helminthiases. (xv) Taeniasis and neurocysticercosis. (xvi) Trachoma. (xvii) Yaws. 399OO–1. Surveillance regarding neglected diseases of poverty in the United States (a) In general The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall award grants to States to carry out activities relating to implementing a surveillance system to determine the prevalence, incidence, and distribution of neglected diseases of poverty, particularly those that most impact individuals in the United States, including toxocariasis, cysticercosis, Chagas disease, toxoplasmosis, trichomoniasis, hookworm infection, and Dengue Fever and related arbovirus infections. (b) Considerations In awarding grants under subsection (a), the Secretary shall use the findings in the initial report of the Interagency Task Force on Neglected Diseases of Poverty in the United States under section 399OO(c) to identify and prioritize geographic locations and communities that have the highest estimated prevalence of, or have populations at greatest risk of acquiring, neglected diseases of poverty, particularly those described in subsection (a). 399OO–2. Support for individuals at risk for neglected diseases of poverty (a) In general The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall award grants or cooperative agreements to Federally qualified health